0.17Open0.17Pre Close0 Volume0 Open Interest89.00Strike Price0.00Turnover4776.76%IV15.52%PremiumDec 13, 2024Expiry Date0.00Intrinsic Value100Multiplier-1DDays to Expiry0.17Extrinsic Value100Contract SizeAmericanOptions Type0.0596Delta0.0173Gamma454.06Leverage Ratio-308.6289Theta0.0000Rho27.07Eff Leverage0.0002Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet